Condition
Pulmonary Hypertension (Diagnosis)
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Recruiting2
Enrolling By Invitation1
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07057466Recruiting
Prospective Evaluation of AI-ECG for SHD Detection
NCT07344207Not ApplicableNot Yet RecruitingPrimary
GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial)
NCT05473520Phase 3Recruiting
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
NCT05942859Enrolling By InvitationPrimary
Applying Artificial Intelligence to the 12 Lead ECG for the Diagnosis of Pulmonary Hypertension: an Observational Study
Showing all 4 trials